Solexa Taps New England Biolabs to Supply Reagents, Manufacture SBS Polymerase | GenomeWeb
NEW YORK (GenomeWeb News) — Solexa today said it has tapped New England Biolabs to provide it with “certain key enzymes and other reagents” for its genome-analysis system, and to manufacture its sequencing-by-synthesis polymerase.
 
Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.